Drug class

Attention Deficit Hyperactivity Disorder (ADHD) Agents

Attention Deficit Hyperactivity Disorder (ADHD) Agents comprise a therapeutic drug class utilized to manage the core symptoms of ADHD, including inattention, impulsivity, and hyperactivity. Read more about Attention Deficit Hyperactivity Disorder (ADHD) Agents

261 drugs in this class 104 manufacturers

Advertisement

Drugs in Attention Deficit Hyperactivity Disorder (ADHD) Agents

Showing 226–234 of 261 drugs

LISDEXAMFETAMINE DIMESYLATE

AMPHETAMINES/ANOREXIANTS/STIMULANTS · ATTENTION-DEFICIT HYPERACTIVITY DISORDER ·+1
Amneal Pharmaceuticals

LISDEXAMFETAMINE DIMESYLATE

AMPHETAMINES/ANOREXIANTS/STIMULANTS · ATTENTION-DEFICIT HYPERACTIVITY DISORDER ·+1
Hikma Pharmaceuticals USA

METHAMPHETAMINE HCL

AMPHETAMINES/ANOREXIANTS/STIMULANTS · ATTENTION-DEFICIT HYPERACTIVITY DISORDER
Hikma Pharmaceuticals USA
Filter & compare in the drug finder → Opens the drug finder with Attention Deficit Hyperactivity Disorder (ADHD) Agents preselected. Add indication or manufacturer filters there.

About Attention Deficit Hyperactivity Disorder (ADHD) Agents.

Attention Deficit Hyperactivity Disorder (ADHD) Agents comprise a therapeutic drug class utilized to manage the core symptoms of ADHD, including inattention, impulsivity, and hyperactivity.

This class encompasses both central nervous system stimulants, such as amphetamines and methylphenidate derivatives, and non-stimulant medications, including selective norepinephrine reuptake inhibitors and central alpha-2 adrenergic agonists.

Mechanistically, these agents enhance prefrontal cortical functioning and neurotransmission by increasing extracellular levels or signaling of norepinephrine and dopamine.

Beyond their primary indication for ADHD in pediatric and adult populations, select agents within this class carry approved indications for conditions such as narcolepsy and binge eating disorder.